ints in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit."},"activity_number":"","additional_info":null},{"id":366,"credit":5.25,"accreditation":{"id":1,"image":null,"title":"AMA PRA Category 1 Credit™","description":"The Binaytara is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara designates this live activity for a maximum of {credit} {title}. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to {credit} hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission."},"activity_number":"","additional_info":null},{"id":367,"credit":5.25,"accreditation":{"id":4,"image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/4f570da2-09d4-45b7-2ba3-751609b94100/Icon","title":"ACPE Pharmacy","description":"$23"},"activity_number":"","additional_info":null}],"additional_tax":null,"exhibitor_link":"https://www.sponsorships.binaytara.org/STCLOUDONC","homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/0f499623-6d5c-4611-79b6-b8568a922300/public","additional_info":"","target_audience":"

Hematologists/ Oncologists
Oncology Fellows
NPs/PAs
Pharmacists
Nurses
Researchers and others

","meta_description":"","calculated_credit":null,"learning_objectives":"

At the conclusion of this activity, participants will be able to:

Apply recent, practice-changing clinical research to the management of patients with hematologic malignancies and solid tumors.
Design and implement individualized treatment plans aligned with updated clinical guidelines, expert consensus, and emerging evidence.
Interpret and utilize tumor biomarkers, gene signatures, and molecular profiling to inform treatment selection and improve patient outcomes.
Identify appropriate patients for referral to relevant clinical trials to increase access to novel and emerging therapies.
Critically evaluate new studies and evolving data to enhance clinical decision-making and support continuous improvement in oncology care.

","organizing_committee":"

Conference Director:

Binay Shah, MD, MHA - Binaytara

Conference Co-Chairs:

Binoy Yohannan, MD - University of Minnesota
Pavan Bhamidipati, MD - CentraCare

Planning Committee:

Siddhartha Yadav, MD - Mayo Clinic

","price_additional_info":null,"accreditation_additonal_info":"# Acknowledgement of Commercial Support\nThis activity is supported with an Independent Medical Education grant from Gilead Sciences. "},"programData":[{"id":1769546612638,"title":"Session 1: GI Oncology","start":"2026-05-02T13:25:00.000Z","end":"2026-05-02T14:25:00.000Z","description":"","raw_faculty":[{"id":2073,"role":"session_chair","uuid":

Conferences

Organizing Committee:

Target Audience:

Learning Objectives: